BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16335853)

  • 1. A pharmacological approach to gastric acid inhibition.
    Esplugues JV
    Drugs; 2005; 65 Suppl 1():7-12. PubMed ID: 16335853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising acid inhibition treatment.
    Gomollón F; Calvet X
    Drugs; 2005; 65 Suppl 1():25-33. PubMed ID: 16335855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic properties of proton pump inhibitors.
    Welage LS
    Pharmacotherapy; 2003 Oct; 23(10 Pt 2):74S-80S. PubMed ID: 14587961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G; Shin JM; Howden CW
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is potent acid inhibition, and how can it be achieved?
    Calvet X; Gomollón F
    Drugs; 2005; 65 Suppl 1():13-23. PubMed ID: 16335854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J; Louis E; Persy V; Urbain D
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of potent gastric acid inhibition.
    Martín de Argila C
    Drugs; 2005; 65 Suppl 1():97-104. PubMed ID: 16335863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
    Corinaldesi R; Ghidini C; Ricci Maccarini M; Santaguida P; Fratesi E; Barbara G; Stanghellini V
    Ital J Gastroenterol; 1990; 22 Suppl 1():2-4. PubMed ID: 1983421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of neem for controlling gastric hyperacidity and ulcer.
    Maity P; Biswas K; Chattopadhyay I; Banerjee RK; Bandyopadhyay U
    Phytother Res; 2009 Jun; 23(6):747-55. PubMed ID: 19140119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-pump inhibitors are the treatment of choice in acid-related disease.
    Brunner G
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S9-13. PubMed ID: 8930574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse effects of drugs for peptic ulcer diseases].
    Haruma K; Kamada T; Shiotani A
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():266-71. PubMed ID: 23156519
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 14. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proton pump inhibitors: Tenatoprazole (TU-199)].
    Nakamura T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():650-4. PubMed ID: 11979864
    [No Abstract]   [Full Text] [Related]  

  • 18. The continuing development of gastric acid pump inhibitors.
    Sachs G; Shin JM; Besancon M; Prinz C
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():4-12, discussion 29-31. PubMed ID: 8387826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.